Everolimus: In Advanced Renal Cell Carcinoma

Author： Garnock-Jones Karly P. Keating Gillian M.

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.15, 2009-10, pp. : 2115-2124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus for the treatment of advanced renal cell carcinoma

By Amato Robert

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1143-1155

Informa Healthcare

Access to resources Recommend Favorite

The UK NICE has not recommended everolimus [Afinitor] as second-line treatment for advanced renal cell carcinoma.

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 627, 2011-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Temsirolimus: In Advanced Renal Cell Carcinoma

By Simpson Dene Curran Monique P.

Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. : 631-638

Adis International

Access to resources Recommend Favorite

Reflex sympathetic dystrophy in patients with metastatic renal cell carcinoma treated with Everolimus

By Massard Christophe Fizazi Karim Gross-Goupil Marine Escudier Bernard

Investigational New Drugs, Vol. 28, Iss. 6, 2010-12 ,pp. : 879-881

Springer Publishing Company

Access to resources Recommend Favorite

Experimental therapy for advanced renal cell carcinoma

By Hutson Thomas E Figlin Robert A

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1693-1702

Informa Healthcare

Access to resources Recommend Favorite